Author:

Johan Maertens, Axel Glasmacher, Dominik Selleslag, Angela Ngai, Desmond Ryan, Melissa Layton, Arlene Taylor, Carole Sable, and Nicholas Kartsonis

Date: 8 June 2005

Abstract:

There has been minimal clinical experience with the use ofthe Aspergillus galactomannan enzyme-linked immunosorbentassay (ELISA) for patients receiving echinocandin therapy.We reviewed the experience with the galactomannanELISA for 17 patients in a study of caspofungin treatmentfor invasive aspergillosis. The rate of successful outcomes forthese patients was similar to that overall for participants inthe study. Trends in antigenemia levels correlated with clinicaland radiographic findings.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.

I understand (click to accept and view download link)

---